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The aim of this study was to evaluate the impact of actual rotational setup errors 
on dose distributions in intracranial stereotactic radiotherapy (SRT) with differ-
ent alternatives for treatment position selection. A total of 38 SRT fractions from 
18 patients were retrospectively evaluated with rotational setup errors obtained from 
actual treatments. The planning computed tomography (CT) images were rotated 
according to online cone-beam CT (CBCT) images and the dose distribution was 
recalculated to the rotated CT images using three different patient positionings 
derived from: 1) an automatic 6D match neglecting rotation correction (Auto6D); 
2) an automatic 3D match (Auto3D); and 3) a manual 3D match from actual treat-
ment (Treat3D). The mean conformity index (CI) was 0.92 for the original plans and 
0.91 for the Auto6D plans. The mean CI decreased significantly (p < 0.01) to 0.78 
and 0.80 for the Auto3D and the Treat3D plans, respectively. The mean minimum 
dose of the planning target volume (PTVmin) was 91.9% of the prescribed dose 
for the original plans and 92.1% for the Auto6D plans, while for the Auto3D and 
the Treat3D plans PTVmin decreased significantly (p < 0.01) to 78.9% and 80.2%, 
respectively. No significant differences were seen between the Auto6D and the 
original treatment plans in terms of the dose parameters. However, the Auto3D and 
the Treat3D plans were statistically significantly inferior (p < 0.01) to the Auto6D 
and the original plans. In addition, a significant negative correlation (p < 0.01, |r| 
> 0.38) was found in the Auto3D and the Treat3D cases between the rotation error 
and CI, PTVmin or minimum dose of gross tumour volume. In SRT, a treatment 
plan of comparable quality to 6D rotation correction can be achieved by using 6D 
registration without a rotational correction in the selection of patient positioning. 
This was demonstrated for typical rotation errors seen in clinical practice.
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I. INTRODUCTION
Brain metastases occur in 10%–30% of all cancer patients.(1) Treatment options are whole 
brain radiotherapy, local therapies (SRT or surgery), and steroids. Several trials have shown a 
benefit in local control, quality of life, and even improved survival for single- or oligometastatic 
patients treated with SRT.(2,3,4)
In SRT, small brain lesions are treated with small GTV-to-PTV margins in a single or few 
fractions. Because of the relatively high dose per fraction (typically 6-21 Gy per fraction), 
steep dose gradients are required around the planning target volume (PTV) to avoid damage 
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to surrounding organs, mainly the central nervous system.(5) Target localization uncertainty 
should be kept very small (typically within 1 mm) in SRT to not compromise the local control 
of the treatment(6) and to minimize the risk of injury to the surrounding brain parenchyma.(7)
SRT presumes adequate patient immobilization. Thermoplastic stereotactic masks are nowa-
days commonly used in SRT treatments. These have been validated in many studies as fulfilling 
the high accuracy standard of SRT.(8,9) Image-guidance with orthogonal kV-images,(10) oblique 
images,(11) cone-beam computed tomography (CBCT) images,(12) reflecting markers with bite 
blocks,(13) and, more recently, patient surface matching systems(14) have shown to be sufficent 
in patient positioning in SRT keeping the residual setup errors under the desired limits.
Intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy 
(VMAT) have increased the dose conformity to PTVs and decreased the dose to normal tissues 
when compared to traditional static beams in linear accelerator-based treatments.(15) The use 
of VMAT also decreases the overall treatment time, reducing the possibility of intrafraction 
movements by the patient. The use of flattering filter-free (FFF) beams decreases the treatment 
time even further in high dose per fraction treatments.(16)
To further increase accuracy in cranial SRT, patient rotational setup errors can be corrected 
using a six degrees of freedom (6DOF) couch.(17,18,19) In all of these studies, the correction of 
the rotational setup error increased plan quality and organ-at-risk (OAR) sparing. It is evident 
that in the patient setup, the use of the 6DOF couch improves treatment quality. However, the 
6DOF couch may not be available in many cancer centers due to the high cost. Gevaert et al.(18) 
compared the calculated dose with and without rotational corrections and concluded a loss of 
5% dose coverage when rotational correction was not used, pointing to a 0.5° rotation error as 
a threshold angle for correction.
The aim of this study was to evaluate the added value of the use of 6DOF registration in 
treatment without the presence of the 6DOF couch system. For this purpose, only translational 
corrections were taken from the 6DOF registration and the dose was recalculated using this 6D 
patient positioning on rotated CT images to illustrate the effect of uncorrected actual rotations 
on dose distribution. The resulting dose distribution was compared to that of the original plan 
and to those obtained by accounting for residual position errors from the 3DOF registration 
and the actual treatment localized by a physician.
 
II. MATERIALS AND METHODS
Eighteen single- or oligometastatic SRT patients with a total of 38 fractions were retrospec-
tively evaluated in this study. The number of treated fractions ranged from a single fraction to 
5 fractions, depending on the tumor size and patient-specific details. Patients were immobilized 
using the BrainLab mask system (Brainlab AG, Feldkirchen, Germany). A slice thickness of 
1 mm was used in the initial treatment planning CT (Philips Big Bore, Philips Medical Systems, 
Fitchburg, WI). 6D registration was used between the recent MRI and planning CT in Eclipse 
registration software (Aria 11, Varian Medical Systems, Palo Alto, CA). Treatment contouring 
and planning were performed with the Eclipse v.11 treatment planning system (Varian Medical 
Systems). GTV-to-PTV margins of 1–2 mm were used. The VMAT technique (Rapid Arc, Varian 
Medical Systems) with noncoplanar or coplanar subarcs was used in the treatment planning with 
6 MV or 6 MV flattening filter-free (6MV-FFF) beams. High definition multileaf collimation 
with leaf width of 2.5 mm was used in the planning. The dose calculation was performed with 
a grid size of 1 mm using anisotropic analytical algorithm v.11 (Varian Medical Systems). The 
treatments were delivered on a TrueBeam STx 1.6 with HD-MLC (Varian Medical Systems). 
Patient positioning was based on online CBCT images with a slice thickness of 2 mm.
The CBCT images were retrospectively analyzed. A schematic illustration of the workflow 
and the coordinate system are presented in Fig. 1. An automatic 6D registration based on skull 
volume was performed between the CBCT and original planning CT (CTplan) using Eclipse 
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registration software (Varian Medical Systems). The resulting rotational deviations in all 3D 
directions (pitch, roll, yaw) were used in the rotation of the original CT images so that the result-
ing rotated CT (CTrot) presented the actual treatment orientation. The rotation isocenter was 
the center of the CT images. The CT rotation was done using homemade software on Matlab 
(The MathWorks, Inc., Natick, MA). After rotation, the new CTrot images were matched by 
automatic 6D registration to the CBCT image (CTrot-CBCT 6D). No rotational deviations 
should be seen in this registration.
The actual treatment position (Treat3D) obtained from the oncologist’s 3D match was marked 
on the CBCT image and copied onto CTrot by using an automatic 6D registration between 
the CBCT and CTrot. Automatic 3D/6D registrations were used to copy the treatment position 
points for the Auto3D/Auto6D plans from CTplan to CTrot, respectively. All the registrations 
were done using the skull as the volume of interest. The dose distributions with actual rotations 
were calculated in CTrot for three different positionings of the patient — Treat3D, Auto3D, and 
Auto6D — and compared to the original treatment plan (planned).
To evaluate the target coverage and plan quality, the Paddick conformity index (CI) and 
gradient index (GI) were used.(20,21) CI is defined as 
  (1)
 
CI = 
V100PTV
VPTV
V100PTV
V100
in which V100PTV is the prescribed dose volume in PTV, VPTV is the PTV volume, and V100 
is the volume which receives the prescribed dose. CI =1 means the best target coverage and 
lower values indicate a worse plan quality. GI is defined by 
  (2)
 
GI = 
V50
V100
in which V50 is the volume which receives higher than half of the prescribed dose. GI value 
increases as the dose gradient outside the target volume becomes shallower, indicating worse 
plan quality.
Fig. 1. Workflow of the different image registrations and definition of rotations to construct the needed CT image set for 
localizations and dose calculations. The coordinate system with rotation axes is also presented.
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The Wilcoxon matched-pairs, signed-rank test (SPSS, v22, IBM Corp., Armonk, NY) for 
nonparametrically distributed data was performed to test the differences between the groups. 
Statistical significance was considered at p < 0.01 (two-tailed, |Z| > 2.576) including the 
Bonferroni correction between the groups planned–Auto6D, planned–Auto3D, planned–Treat3D, 
Auto6D–Auto3D, and Auto6D–Treat3D, which was made by dividing 0.05 by number of com-
parisons (i.e., by five).
The dose distributions in four different cases (planned, Treat3D, Auto3D, and Auto6D) were 
studied for 38 different patient setups. The mean PTVvol was 8.0 cm3 (± 7.6 cm3), with a 
maximum volume of 26.6 cm3 and a minimum volume of 0.9 cm3. The locations and shapes 
of the PTVs are presented in Fig. 2. From 38 patient setups, there were two patients with more 
than one lesion and treatment isocenter was located outside of the PTV. One patient had 1 frac-
tion with two lesions and the other had 3 fractions with three lesions resulting in four different 
patient setups.
To demonstrate the use of 6D registration without rotational corrections for complex shaped 
targets or two separate spherical target volumes with reasonably large rotational errors, two 
patient examples are given. In the first example, the PTV is quite large (14.6 cm3) and complex 
in shape. The treatment plan consisted of two slightly noncoplanar full arcs. In the second 
example, two spherical PTVs were treated simultaneously using four noncoplanar half arcs. 
The volumes of the PTVs were 20.1 cm3 and 5.2 cm3. The distance between the PTVs was 
3 cm. The GTV-to-PTV margin was 2 mm in both examples.
 
III. RESULTS 
The mean rotational setup errors were -0.29° ± 0.88° (range from -2.1° to 1.6°), -0.26° ± 0.95° 
(from -2.0° to 2.4°) and -0.47° ± 0.80° (from -2.7° to 0.8°) for the pitch, roll and yaw rotations, 
respectively. The mean distance between actual treatment positioning and the position obtained 
from Auto6D registration was 1.2 mm (± 0.6 mm), ranging from 2.6 mm to 0.1 mm, while the 
corresponding distance between treatment position and that obtained from the Auto3D was 
1.7 mm (± 0.8 mm), altering from 3.8 mm to 0.2 mm.
CI, GI, maximum, and minimum doses of PTV and GTV (PTVmax, PTVmin, GTVmin) 
were investigated for each plan, and the mean, standard deviation (SD), minimum (Min), and 
maximum (Max) values are presented in Table 1 for each investigated group. The Wilcoxon 
test results for the groups planned–Auto6D, planned–Auto3D, planned–Treat3D, Auto6D–Auto3D, 
and Auto6D–Treat3D are shown in Table 2.
These results show that the plans from the Auto6D group have almost the same mean CI, 
PTVmin, and GTVmin values as the planned group and no statistically significant difference 
was found between these two groups. The mean CI, PTVmin, and GTVmin values were reduced 
Fig. 2. Schematic illustration of the investigated PTVs for 18 patients.
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significantly (p < 0.01) for the Auto3D and Treat3D plans when compared to the original and 
Auto6D plans. Only a minor change was seen in the PTVmax among all the investigated groups. 
No significant difference was seen in GI values between the groups.
Significant correlation (p < 0.01) was found between the square root of the quadratic sum 
of the rotations (quadratic sum) and CI in the Auto3D group, rauto3D = -0.46. In the Treat3D 
group, the correlation was nearly significant, rtreat3D = -0.38 (p = 0.02). Significant correlation 
(p < 0.01) was found between the rotation and PTVmin, rauto3D = -0.54 and rtreat3D = -0.52, 
and between rotation and GTVmin, rauto3D = -0.54 and rtreat3D = -0.42. The correlation was 
calculated for the percentage difference from the original plan values for the CI, PTVmin, and 
GTVmin values by dividing those with the original plan values to minimize the effect of varia-
tion in the original plans. No significant correlation was found in the Auto6D case between the 
rotation and dose parameters (rCI = -0.24 (p = 0.15), rPTVmin = -0.33 (p = 0.04), rGTVmin = -0.26 
(p = 0.11)). CI, PTVmin, and GTVmin scaled to original plan values with respect to quadratic 
Table 1. The mean, SD, Min, and Max results for CI, GI, PTVmax, PTVmin, and GTVmin for the four different groups.
 CI Mean SD Min Max
 planned 0.92 0.02 0.82 0.94
 Auto6D 0.91 0.03 0.82 0.94
 Auto3D 0.78 0.12 0.43 0.94
 Treat3D 0.80 0.10 0.62 0.93
 GI Mean SD Min Max
 planned 4.23 0.83 3.14 5.93
 Auto6D 4.23 0.82 3.14 5.91
 Auto3D 4.24 0.83 3.14 5.94
 Treat3D 4.22 0.83 3.12 5.92
 PTVmax Mean SD Min Max
 planned 119.8 6.5 110.6 136.5
 Auto6D 119.8 6.4 110.6 136.4
 Auto3D 119.5 6.4 110.5 136.6
 Treat3D 119.9 6.6 110.6 136.8
 PTVmin Mean SD Min Max
 planned 91.9 3.1 84.9 96.4
 Auto6D 92.1 4.0 81.8 97.5
 Auto3D 78.9 11.7 53.7 97.0
 Treat3D 80.2 10.7 55.1 96.1
 GTVmin Mean SD Min Max
 planned 105.5 3.6 98.2 115.6
 Auto6D 105.7 3.4 98.4 115.6
 Auto3D 99.9 5.4 82.7 112.8
 Treat3D 101.1 5.7 90.2 115.1
Table 2. The Z- and p-values from the Wilcoxon signed-rank test for the related samples between the groups (|Z|/p). 
  CI GI PTVmax PTVmin GTVmin
 planned – Auto6D 1.62/0.11 1.17/0.24 0.30/0.76 2.05/0.04 1.36/0.17
 planned – Auto3D 5.29/<0.01
a 1.33/0.19 3.10/<0.01a 5.14/<0.01a 5.09/<0.01a
 planned – Treat3D 5.34/<0.01
a 1.95/0.05 0.76/0.44 5.30/<0.01a 4.30/<0.01a
 Auto6D – Auto3D 5.29/<0.01
a 2.42/0.02 3.09/<0.01a 5.30/<0.01a 5.27/<0.01a
 Auto6D – Treat3D 5.30/<0.01
a 1.02/0.31 0.23/0.82 5.29/<0.01a 4.67/<0.01a
a Groups with |Z| > 2.567, p < 0.01 were considered to have a significant difference.
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sum of the rotations are presented in Fig. 3. The multiple lesion cases are shown separately in 
Fig. 3. These images show a threshold of quadratic sum of the rotations of around 0.5° when 
all scaled parameters are under the limits of CI < 90%, PTVmin < 90%, and GTVmin < 95% 
for the Auto3D group. For the quadratic sum higher than 0.5°, most of the scaled parameters 
are under those limits.
In the first example, the PTV is nonspherical in shape, as seen in Fig. 4(a). The rotational 
setup errors were 0.9°, -1.6°, and 2.7° for the pitch, roll, and yaw rotations, respectively. The 
distance from the treatment positioning of the patient to the positioning given by Auto6D reg-
istration was 2.2 mm, and the distance from the treatment positioning to that given by Auto3D 
registration was 0.9 mm. In the second example, where there are two separate targets (Fig. 4(b)), 
the rotational setup errors were -1.8°, -0.3°, and 0.2°, the pitch, roll, and yaw rotations, respec-
tively. The distance from the treatment positioning to the Auto6D positioning was 1.0 mm, and 
Fig. 3. The percentage difference from the original plan to the CI, PTVmin, and GTVmin values with respect to the 
 quadratic sum of the rotations. Auto6D plans are indicated by a square (□), Auto3D plans by triangle (∆), and Treat3D plans 
by a circle (○). S indicates single lesion and M is for multiple (2–3) lesions. The multiple lesions are shown by filled 
symbols for Auto6D/3D plans and by a line (-) for Treat3D plans.
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the distance from the treatment positioning to the Auto3D positioning was 0.8 mm. The isodose 
lines for the 100% prescription isodose and the dose-volume histograms (DVHs) for PTV and 
GTV are shown in Fig. 4 for the different cases (planned, Auto6D, Auto3D, Treat3D). It is evident 
from the DVH figures that the coverages for PTV and GTV are decreased significantly for the 
Auto3D and Treat3D plans, while for Auto6D the coverages are almost identical to the original 
plan in both examples.
 
IV. DISCUSSION
6DOF couches have become a common tool in stereotactic brain treatments. Previously, the 
6DOF couch has been shown to improve the treatment quality by taking into account daily 
rotational errors.(18,19) Common to these studies is that they compare the 6D registration with 
rotational correction results only to those of the 3D registration, which is also shown in this 
study to significantly impair the dose distribution. We have shown that by appropriate selection 
of the patient positioning (Auto6D) in brain SRT treatments, a comparable treatment quality is 
achieved without the correction of rotational errors. The investigated PTVs were very different 
in shape, size, and location. Thus, the results give the impression that the Auto6D method works 
best, not only for spherical PTVs, but also for more complex PTV shapes and even for several 
simultaneous targets (the amount of targets varied from one to three). This is demonstrated in 
Fig. 4. The examples of two patients (A and B) are shown with PTV outlines (red), isodoses of the prescription dose of 
100% for the original plans (orange), Auto6D plans (cyan), Auto3D plans (brown), and Treat3D plans (green). The locations 
of the patient positionings are also shown for Auto6D (6D), Auto3D (3D), and Treat3D (green +). On the left, the DVHs are 
shown for each case’s PTVs and GTVs.
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the examples given of nonspherical PTVs. Although there were only two cases and 4 fractions 
with multiple targets, their results give also an impression that the Auto6D method is the best 
method for patient positioning amongst the studied methods also, for multiple targets, and 
that at least it is better than the Auto3D. However, more studies might be needed to make any 
conclusions for the multiple target cases.
Gevaert et al.(18) proposed 0.5° as a threshold angle for the correction of rotation errors to 
keep the dose coverage of PTV over 95% with the 3D registration. Our data suggest that a 
3D match is suboptimal in terms of CI, PTVmin, and GTVmin when the quadratic sum of the 
rotations exceeds 0.5° (scaled parameters CI < 90%, PTVmin < 90%, and GTVmin < 95% in 
Fig. 3). For 6D registration, our results suggest that the threshold of rotations could be even 
larger. The quadratic sum of rotation values of 2°–3° still give adequate plan quality values for 
scaled CI < 95%, PTVmin < 95%, and GTVmin < 95%. Although the quadratic sum does not 
describe physically the actual rotation angle, it still seems to provide reasonable one-number 
measure of overall rotation.
These findings are demonstrated to be valid for brain metastases treated with the SRT. The 
used margins were 1–2 mm. For stereotactic radiosurgery (SRS), the clinical tolerances and 
practices are different and these findings may not be directly valid for SRS treatments.
Besides the setup error, the total treatment accuracy depends also on the patient intrafrac-
tion movement(18) and machine isocenter accuracy. These are not considered in this work, but 
should be kept in mind in estimation of sufficient margins for the SRT. With mask fixation 
the intrafraction movement is very small, but not negligible. Verbakel et al.(8) found that, for 
BrainLab mask system, the intrafraction motion was randomly distributed around the zero in 
every direction and that the maximum deviation was 1 mm and 1° when the average treatment 
time was 16 min. For shorter treatment times the deviation might be less.
In this paper, we have shown the 6D registration to be superior over 3D registration. However, 
the 6D registration may not be possible in all online registration software, and implementation 
in daily practice might be difficult. At least on the newest versions of Varian (Varian Medical 
Systems) and Elekta (Elekta Ltd., Crawley, UK) accelerators and in the ExacTrac (Brainlab) 
system this option is available. These results apply to Varian 6D registration and need to be 
confirmed before adaptation to the 6D registration systems of other vendors.
 
V. CONCLUSION
We conclude that the outcome of SRT treatments without the option of 6DOF couch could be 
improved by using 6D registration in the treatment setup. This was demonstrated for typical 
actual rotation errors below 3° seen in treatment situations.
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